Gene Query: OSER1

Dataset Description Geneva Score
Gene expression in PANC1 cells treated with Rakicidin 59.21
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 50.32
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 46.08
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 46.07
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 37.28
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 37.28
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 36.46
Transcriptome analysis in Neobractatin treated cells 30.92
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 30.41
BAF controls genome accessibility 30.18
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 29.48
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 27.63
Unique features and clinical importance of acute alloreactive immune responses 26.94
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 25.16
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 24.94
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 24.38
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 21.74
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 21.13
Transcriptional profile in human S. haematobium infection 20.77
Effect of BB608 on Gene Expression in HNSCC Cell Line 19.52
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 19.47
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 19.47
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 19.4
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 18.31
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 17.6
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 17.36
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 17.36
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 17.34
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 16.99
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 16.99
Tracking of dCas9-methyltransferase footprints 16.75
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 16.28
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 16.16
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 16.0
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 16.0
Effect of disulfiram treatment on pediatric high grade glioma 15.45
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 15.05
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 14.75
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 14.72
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 14.72
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 14.7
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 14.7
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 14.42
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 14.21
A Unique Epigenomic Landscape Defines Human Erythropoiesis 14.21
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 14.15
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 13.99
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 13.8
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 13.8
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 13.7
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 13.45
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 13.29
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 13.25
Genetic-to-epigenetic Therapy for Pancreatic Cancer 13.23
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 12.95
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 12.64
RNAseq Study in CC-671 Treated Cal-51 Cells 12.43
Cell responses to dysregulated VZV-induced cell-cell fusion 12.28
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 12.26
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 12.26
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 12.23
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 12.12
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 11.82
Identifying the molecular mode of action of itraconazole in colorectal cancer 11.79
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 11.72
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 11.61
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 11.6
Identification of global regulators of T-helper cell lineage specification 11.6
HEK293 TFAM Knockout Expression Study 11.53
Expression by CD133+ cells isolated from the adult human exocrine pancreas 11.26
RNA-seq of YB5 cells treated with Proscillaridin A 10.91
RNA Seq of HMVEC under hypoxia 10.7
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 10.7
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 10.67
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 10.62
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 10.52
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 10.42
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 10.42
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 10.33
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 10.27
mRNA expression profile of Lymphocytes 10.22
DART-seq: an antibody-free method for global m6A detection 10.14
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 10.06
Landscape of H3K4me3 in human CD19 cells 9.98
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 9.98
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 9.92
The regulartory role of ZCCHC24 in splicing machinery 9.87
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 9.75
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 9.64
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 9.6
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 9.6
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 9.49
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 9.47
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 9.47
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 9.45
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 9.42
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 9.42
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 9.34
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 9.26
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 9.22
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 9.18
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 9.11
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 9.1
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 9.1
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 9.08
Neonatal and adult human testis defined at the single-cell level 9.03
RNAseq Analysis in glioblastoma cells treated with Mepazine 9.0
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 9.0
p63 controls the enhancer landscape during keratinocyte differentiation 8.93
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 8.81
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 8.76
Human HAP1 cells before and after nutrient deprivation 8.76
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 8.71
Noncoding regions are the main source of targetable tumor-specific antigens 8.7
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 8.67
Tumor exosome integrins determine organotropic metastasis 8.66
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 8.48
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 8.38
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 8.29
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 8.15
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 8.13
Genome wide miR-191 target profile determined by RIP and gene expression profiling 8.08
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 8.08
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 8.0
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 7.93
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  7.92
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 7.89
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 7.84
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 7.81
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 7.8
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 7.79
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 7.72
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 7.69
Energy Metabolism during Anchorage-Independence 7.64
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 7.57
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 7.48
Paxillin regulates genomic networks in prostate cancer [LNCaP] 7.46
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 7.43
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 7.43
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 7.43
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 7.41
mRNA-sequencing of breast cancer subtypes and normal tissue 7.38
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 7.35
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 7.3
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 7.22
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 7.17
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 7.16
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 7.11
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 7.08
Regulation of protein translation during mitosis 7.04
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 7.03
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 7.0
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 6.99
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 6.96
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 6.95
Stem and effector CD8 T-cells from human cancers 6.84
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 6.83
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 6.83
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 6.83
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 6.81
RNA-seq analysis of differentiating human erythroblasts 6.8
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 6.78
RNA-seq differential expression studies: more sequence, or more replication? 6.74
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 6.73
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 6.73
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 6.69
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 6.69
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 6.68
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 6.6
U1 snRNP telescripting regulates size-function stratified human genome 6.58
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 6.56
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 6.56
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 6.56
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 6.53
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 6.53
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 6.53
Overexpression of NFIB and YBX1 in MCF-7 cells 6.51
scRNASeq analysis of cycling cardiomyocytes 6.44
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 6.44
Fbxo32 mediated gene expression program underlies EMT and metastasis 6.43
Capturing the Interactome of Newly Transcribed RNA 6.38
Capturing the Interactome of Newly Transcribed RNA (RICK) 6.38
The Human Testis Cell Atlas via Single-cell RNA-seq 6.37
snRNAs as regulators of alternative splicing 6.31
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 6.31
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 6.26
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 6.24
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 6.19
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 6.18
Overexpression and knockdown experiment for circCSNK1G3 6.18
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 6.17
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 6.16
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 6.1
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 6.08
RNA sequencing of human mammary epithelial cells 6.05
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 6.04
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 6.03
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 6.03
Polarized B -cell functions 5.94
Identification of transcription start sites for human A549 cell line using ReCappable-seq 5.86
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 5.83
Developmental stage specific chromosome architecture in human erythroid cells 5.83
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 5.82
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 5.81
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 5.8
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 5.79
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 5.77
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 5.76
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 5.73
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 5.72
RNA-seq of MCF10A cells and CAF 5.66
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 5.64
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 5.62
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 5.59
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 5.59
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 5.57
The conserved transcriptional landscapes in human spermatogenesis 5.56
Identification of a LIF-responsive replication-competent human β cell 5.52
Identification of Sin3B regulated genes during quiescence 5.49
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 5.47
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 5.47
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 5.42
Paxillin regulates genomic networks in prostate cancer [PC3] 5.41
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 5.41
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 5.39
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 5.39
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 5.36
AR-independent prostate cancer is sustained through FGF signaling 5.36
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 5.33
Be1 and Be2 B cells are transcriptionally distinct 5.32
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 5.31
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 5.22
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 5.21
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 5.2
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 5.17
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 5.17
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 5.15
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 5.14
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 5.14
The effect of PPARG inhibition on human angiomyolipoma cells 5.13
SNHG5 siRNA knock down in HCT116 cells 5.12
RNA-seq analysis to identify the genes regulated by p53-SET interplay 5.11
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 5.06
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 5.03
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 4.94
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 4.94
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 4.92
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 4.92
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 4.9
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 4.9
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 4.87
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 4.82
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 4.8
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 4.79
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 4.73
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 4.7
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 4.7
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 4.66
Intron retention induced by microsatellite expansions as a disease biomarker. 4.66
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 4.65
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 4.62
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 4.61
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 4.6
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 4.59
Patient-derived luminal breast cancer xenografts with progestins 4.59
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 4.56
Role of cervicovaginal microbiota in genital inflammation 4.55
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 4.54
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 4.52
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 4.51
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 4.51
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 4.5
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 4.49
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 4.42
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 4.41
m6A-dependent regulation of messenger RNA stability 4.41
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 4.35
LIN28A Over-expression RNAseq 4.32
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 4.3
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 4.28
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 4.27
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 4.23
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 4.17
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 4.17
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 4.17
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 4.16
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 4.15
Gene expression signatures of innate lymphoid cells from human blood 4.14
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 4.13
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 4.13
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 4.11
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 4.11
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 4.08
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 4.08
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 4.07
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 4.06
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 4.0
SLAM-seq for K562 endogenous mRNA decay 3.94
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 3.9
RNA-seq data 3.88
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 3.85
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 3.85
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 3.79
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 3.75
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 3.75
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 3.67
BACH2 in human plasma cell fate decision 3.65
Gene expression profile of multiple myeloma cell lines treated with CB-5083 3.62
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 3.6
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 3.6
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 3.55
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 3.55
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 3.51
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 3.5
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.5
Investigate A2M treatment on human prostate cancer xenograft in mice 3.47
Investigate A2M treatment on human prostate cancer and mouse liver 3.47
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 3.41
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 3.4
RNA-seq in transgenic cells 3.4
Effect of from Human Umbilical Vein Endothelial Cells 3.4
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 3.37
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 3.32
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 3.32
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 3.28
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 3.28
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 3.24
Generation and persistence of human tissue-resident memory T cells in lung transplantation 3.23
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 3.22
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 3.2
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 3.11
MAIT cell RNA sequencing 3.06
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 3.0
Gene expression profile in breast cancer cells 3.0
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 2.98
Endometrial transcriptome and PGR cistrome in cycling fertile women 2.98
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 2.95
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.91
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 2.88
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 2.85
Changes in human endometrial gland transcriptome over the window of implantation 2.84
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 2.82
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.8
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 2.79
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 2.78
Discovering human diabetes-risk gene function with genetics and physiological assays 2.78
Transcriptional landscape changes during human embryonic stem cell derivation 2.77
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 2.76
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 2.76
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 2.72
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 2.71
naive T cell heterogeneity after neonatal thymectomy 2.7
SETBP1-WT and SETBP1-G870S epigenetic landscapes 2.64
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 2.64
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 2.64
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.64
The bromodomain protein BRD4 regulates splicing during heat shock 2.58
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 2.5
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 2.49
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.48
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.48
CD73 knockdown effect in pancreatic cancer cell lines 2.46
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 2.44
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 2.42
Ribosome profiling upon inhibition of eIF4A 2.29
Dysregulated immune system networks in war veterans with PTSD 2.27
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 2.22
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 2.16
RNA sequencing of GlyH-101-treated MCF-7 cell line 2.15
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 2.11
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 2.1
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 2.1
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 2.07
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 2.03
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.96
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.96
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 1.92
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 1.9
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 1.88
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 1.8
Redifferentiation of expanded human islet β cells by inhibition of ARX 1.75
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.74
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.71
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.7
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.7
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 1.68
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 1.67
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 1.63
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.57
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 1.56
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 1.51
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 1.41
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 1.41
Functional role of CPPED1 in trophoblasts. 1.35
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 1.35
RNA editing in nascent RNA affects pre-mRNA splicing 1.33
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 1.28
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 1.28
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.27
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 1.22
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.22
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.22
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.21
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.2
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 1.2
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 1.19
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 1.13
RNA-Seq analysis of breast cancer cells after shikonin treatment 1.12
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.12
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 1.11
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 1.06
High-resolution comparative analysis of great ape genomes 1.06
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.03
Specific molecular signatures underlie response to decitabine in CMML 1.03
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 1.03
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.01
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 1.01
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.97
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 0.96
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.95
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.95
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.95
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.91
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 0.88
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.87
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 0.83
Primary Human B-cell Temporal Response to CD40L Stimulation 0.81
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.78
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.78
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.78
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 0.78
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 0.78
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 0.77
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 0.77
iPSC derived motor neuron cultures from C9ORF72 carriers 0.76
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.75
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 0.74
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 0.7
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 0.7
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.62
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.61
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 0.6
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 0.6
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.56
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.56
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.56
Human Treg IFNg/IL-10 subpopulations 0.54
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.53
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 0.52
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 0.52
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.51
Single-cell analysis of adult human ovary using 10X genomics 0.49
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.49
The cohesin complex prevents Myc-induced replication stress 0.48
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 0.48
Transcriptome profiling of 5 human adenocarcinoma cell lines 0.46
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 0.46
Gene expression analysis upon mtDNA depletion 0.45
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.45
A single cell reference map for human blood and tissue T cell activation 0.43
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.4
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.4
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.4
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.4
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.4
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.38
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 0.37
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.37
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.37
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.37
Human Treg IL-12 stimulation 0.29
Deep RNA sequencing of the human placental transcriptome 0.27
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 0.27
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.27
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 0.25
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 0.25
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.23
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.22
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.22
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.22
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.21
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.19
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.18
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.16
Molecular analysis of renal cell carcinoma with unclassfied histology 0.14
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.14
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 0.14
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 0.14
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.12
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.1
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 0.09
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.09
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.07
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.06
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  0.06
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.05
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.04
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.03
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.03
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation